US Stock MarketDetailed Quotes

ANRO Alto Neuroscience

Watchlist

4.090
-0.180-4.22%

Close Nov 21 16:00 ET

4.090
0.0000.00%

Post 16:20 ET

110.31MMarket Cap-1920P/E (TTM)

Alto Neuroscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-51.01%-11.73M

-76.25%-11.69M

-45.97%-10.98M

-64.01%-33.45M

-91.40%-11.52M

-7.77M

-6.64M

-7.52M

-120.19%-20.39M

-6.02M

Net income from continuing operations

-83.60%-16.78M

-85.04%-16.03M

-84.20%-13.42M

-31.02%-36.31M

-46.59%-11.22M

---9.14M

---8.66M

---7.28M

-201.62%-27.71M

---7.65M

Operating gains losses

101.77%4K

117.65%18K

2,309.09%243K

-204.34%-385K

82.64%-46K

---226K

---102K

---11K

244.86%369K

---265K

Depreciation and amortization

93.65%122K

0.89%113K

12.79%97K

9.06%373K

15.46%112K

--63K

--112K

--86K

135.86%342K

--97K

Other non cash items

-10.37%147K

461.39%887K

-3.95%170K

157.03%676K

342.50%177K

--164K

--158K

--177K

1,361.11%263K

--40K

Change In working capital

234.05%2.79M

138.33%1.43M

73.87%-255K

-115.24%-698K

-241.32%-1.16M

--834K

--600K

---976K

900.52%4.58M

--818K

-Change in receivables

--0

121.62%8K

-71.93%325K

--0

--295K

--67K

---37K

190.12%1.16M

--1.02M

-Change in prepaid assets

1,007.32%744K

-67.96%124K

-285.56%-1.79M

42.37%-34K

144.17%125K

---82K

--387K

---464K

84.64%-59K

---283K

-Change in payables and accrued expense

228.82%2.04M

794.52%1.31M

421.26%1.53M

-128.42%-989K

-1,742.31%-1.28M

--621K

--146K

---475K

217.23%3.48M

--78K

Cash from discontinued investing activities

Operating cash flow

-51.01%-11.73M

-76.25%-11.69M

-45.97%-10.98M

-64.01%-33.45M

-91.40%-11.52M

---7.77M

---6.64M

---7.52M

-120.19%-20.39M

---6.02M

Investing cash flow

Cash flow from continuing investing activities

-2,237.21%-1.01M

-529.63%-340K

-966.67%-224K

35.79%-470K

-467.74%-352K

-43K

-54K

-21K

-7.65%-732K

-62K

Capital expenditure reported

-2,237.21%-1.01M

-529.63%-340K

-966.67%-224K

35.79%-470K

-467.74%-352K

---43K

---54K

---21K

-7.65%-732K

---62K

Cash from discontinued investing activities

Investing cash flow

-2,237.21%-1.01M

-529.63%-340K

-966.67%-224K

35.79%-470K

-467.74%-352K

---43K

---54K

---21K

-7.65%-732K

---62K

Financing cash flow

Cash flow from continuing financing activities

2,587.76%1.32M

-358.82%-234K

438.24%134.56M

55.59%68.13M

118.81%43.13M

49K

-51K

25M

38.19%43.79M

19.71M

Net issuance payments of debt

----

--0

----

--9.83M

----

Net common stock issuance

--0

--137.58M

320.93%181K

4,425.00%181K

--0

514.29%43K

--4K

Net preferred stock issuance

--0

104.31%70M

349.74%45.15M

---60K

---94K

--25M

7.45%34.26M

--10.04M

Proceeds from stock option exercised by employees

-38.53%67K

41.86%61K

--10K

----

--109K

--43K

--0

----

Net other financing activities

--1.25M

---295K

---3.03M

-501.47%-2.05M

----

-66.34%-341K

---157K

Cash from discontinued financing activities

Financing cash flow

2,587.76%1.32M

-358.82%-234K

438.24%134.56M

55.59%68.13M

118.81%43.13M

--49K

---51K

--25M

38.19%43.79M

--19.71M

Net cash flow

Beginning cash position

228.01%193.62M

213.01%205.9M

70.75%82.55M

88.07%48.34M

47.83%51.29M

--59.03M

--65.78M

--48.34M

541.18%25.71M

--34.7M

Current changes in cash

-47.11%-11.41M

-82.02%-12.27M

606.69%123.35M

50.96%34.21M

129.33%31.26M

---7.76M

---6.74M

--17.46M

4.22%22.66M

--13.63M

Effect of exchange rate changes

-138.89%-7K

54.55%-5K

73.68%-5K

66.67%-8K

-80.00%4K

--18K

---11K

---19K

52.00%-24K

--20K

End cash Position

255.25%182.2M

228.01%193.62M

213.01%205.9M

70.75%82.55M

--51.29M

--59.03M

--65.78M

88.07%48.34M

--48.34M

Free cash flow

-63.05%-12.73M

-79.91%-12.03M

-48.54%-11.21M

-60.55%-33.92M

-95.23%-11.88M

---7.81M

---6.69M

---7.55M

-112.49%-21.13M

---6.08M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-51.01%-11.73M	-76.25%-11.69M	-45.97%-10.98M	-64.01%-33.45M	-91.40%-11.52M	-7.77M	-6.64M	-7.52M	-120.19%-20.39M	-6.02M
Net income from continuing operations	-83.60%-16.78M	-85.04%-16.03M	-84.20%-13.42M	-31.02%-36.31M	-46.59%-11.22M	---9.14M	---8.66M	---7.28M	-201.62%-27.71M	---7.65M
Operating gains losses	101.77%4K	117.65%18K	2,309.09%243K	-204.34%-385K	82.64%-46K	---226K	---102K	---11K	244.86%369K	---265K
Depreciation and amortization	93.65%122K	0.89%113K	12.79%97K	9.06%373K	15.46%112K	--63K	--112K	--86K	135.86%342K	--97K
Other non cash items	-10.37%147K	461.39%887K	-3.95%170K	157.03%676K	342.50%177K	--164K	--158K	--177K	1,361.11%263K	--40K
Change In working capital	234.05%2.79M	138.33%1.43M	73.87%-255K	-115.24%-698K	-241.32%-1.16M	--834K	--600K	---976K	900.52%4.58M	--818K
-Change in receivables	--0	--0	121.62%8K	-71.93%325K	--0	--295K	--67K	---37K	190.12%1.16M	--1.02M
-Change in prepaid assets	1,007.32%744K	-67.96%124K	-285.56%-1.79M	42.37%-34K	144.17%125K	---82K	--387K	---464K	84.64%-59K	---283K
-Change in payables and accrued expense	228.82%2.04M	794.52%1.31M	421.26%1.53M	-128.42%-989K	-1,742.31%-1.28M	--621K	--146K	---475K	217.23%3.48M	--78K
Cash from discontinued investing activities
Operating cash flow	-51.01%-11.73M	-76.25%-11.69M	-45.97%-10.98M	-64.01%-33.45M	-91.40%-11.52M	---7.77M	---6.64M	---7.52M	-120.19%-20.39M	---6.02M
Investing cash flow
Cash flow from continuing investing activities	-2,237.21%-1.01M	-529.63%-340K	-966.67%-224K	35.79%-470K	-467.74%-352K	-43K	-54K	-21K	-7.65%-732K	-62K
Capital expenditure reported	-2,237.21%-1.01M	-529.63%-340K	-966.67%-224K	35.79%-470K	-467.74%-352K	---43K	---54K	---21K	-7.65%-732K	---62K
Cash from discontinued investing activities
Investing cash flow	-2,237.21%-1.01M	-529.63%-340K	-966.67%-224K	35.79%-470K	-467.74%-352K	---43K	---54K	---21K	-7.65%-732K	---62K
Financing cash flow
Cash flow from continuing financing activities	2,587.76%1.32M	-358.82%-234K	438.24%134.56M	55.59%68.13M	118.81%43.13M	49K	-51K	25M	38.19%43.79M	19.71M
Net issuance payments of debt	----	----	----	--0	----	----	----	----	--9.83M	----
Net common stock issuance	--0	--0	--137.58M	320.93%181K	4,425.00%181K	--0	--0	--0	514.29%43K	--4K
Net preferred stock issuance	--0	--0	--0	104.31%70M	349.74%45.15M	---60K	---94K	--25M	7.45%34.26M	--10.04M
Proceeds from stock option exercised by employees	-38.53%67K	41.86%61K	--10K	----	----	--109K	--43K	--0	----	----
Net other financing activities	--1.25M	---295K	---3.03M	-501.47%-2.05M	----	----	----	----	-66.34%-341K	---157K
Cash from discontinued financing activities
Financing cash flow	2,587.76%1.32M	-358.82%-234K	438.24%134.56M	55.59%68.13M	118.81%43.13M	--49K	---51K	--25M	38.19%43.79M	--19.71M
Net cash flow
Beginning cash position	228.01%193.62M	213.01%205.9M	70.75%82.55M	88.07%48.34M	47.83%51.29M	--59.03M	--65.78M	--48.34M	541.18%25.71M	--34.7M
Current changes in cash	-47.11%-11.41M	-82.02%-12.27M	606.69%123.35M	50.96%34.21M	129.33%31.26M	---7.76M	---6.74M	--17.46M	4.22%22.66M	--13.63M
Effect of exchange rate changes	-138.89%-7K	54.55%-5K	73.68%-5K	66.67%-8K	-80.00%4K	--18K	---11K	---19K	52.00%-24K	--20K
End cash Position	255.25%182.2M	228.01%193.62M	213.01%205.9M	70.75%82.55M	70.75%82.55M	--51.29M	--59.03M	--65.78M	88.07%48.34M	--48.34M
Free cash flow	-63.05%-12.73M	-79.91%-12.03M	-48.54%-11.21M	-60.55%-33.92M	-95.23%-11.88M	---7.81M	---6.69M	---7.55M	-112.49%-21.13M	---6.08M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data